Sahlgrenska Center for Cancer Research
Translational cancer research with the patient in focus
Here at Sahlgrenska Center for Cancer Research (SCCR) we focus our research with the patient in mind. This is so that the cancer patient could receive a better care in the future than in today’s society. Through a close collaboration with the Sahlgrenska University Hospital, we at the centre are trying to find new methods and treatments, which later can be tested and applied directly within the cancer care.
Our research groups work widely
Today our 28 research groups work in a wide spectrum of cancer related research questions, but they all have translational cancer research as a common denominator. Example of areas which are studied are brain cancers, lung cancer, breast cancer, melanoma, radiotherapy, prostate cancer and leukaemia. Other research areas at the centre are also epigenetics, ovarian and cervical cancer, sarcoma, neuroendocrine and thyroid cancers, pancreatic cancer and salivary gland tumors.
The research is in some cases used for developing diagnostic and prognostic tools, which in the longer term can improve the cancer care and ensure that the right treatments are being used.
Overbridging post graduate studies
Through the Cancer Research South (CARES) School we at Sahlgrenska Center for Cancer Research also provide courses within cancer research. As for our work, these courses are overbridging research and clinical work as well. CARES is a graduate research school which offers courses to PhD Students at University of Gothenburg and Lund University, which have both been part of the previous strategic program BioCARE.
Latest SCCR publications
- Single-cell triomics analysis of tumor cells infiltrating patient-derived breas… (External link)
- Modeling cancer-associated fibroblast plasticity and breast cancer interactions… (External link)
- Amino acid restriction sensitizes lung cancer cells to ferroptosis via GCN2-dep… (External link)
- Immune-stromal heterogeneity in breast cancer across diverse ancestries: impact… (External link)
- Brain metastasis in stage IV lung adenocarcinoma is frequently missed by sympto… (External link)
- Detecting TP53 mutations in paired liquid and tissue biopsies from patients wit… (External link)
- Worse survival despite indolent features for triple-negative invasive lobular c… (External link)
- SCC publications (before name change) (External link)
